标题
Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors
作者
关键词
DYRK1A, DYRK1B, Kinase Inhibitors, Pyrazolopyridines, Colon cancer, Organoid
出版物
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 47, Issue -, Pages 128226
出版商
Elsevier BV
发表日期
2021-06-26
DOI
10.1016/j.bmcl.2021.128226
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133
- (2020) Yahu A. Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment
- (2019) V. Deshmukh et al. OSTEOARTHRITIS AND CARTILAGE
- LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells
- (2018) Yanmei Zou et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics
- (2018) Dnyandev B. Jarhad et al. JOURNAL OF MEDICINAL CHEMISTRY
- DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
- (2018) Fernanda Neumann et al. Scientific Reports
- Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity
- (2018) Kunal Kumar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation
- (2018) Kunal Kumar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors
- (2018) Anna Czarna et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis
- (2017) Yingying Chen et al. HUMAN PATHOLOGY
- Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma
- (2017) Qingqing Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of DYRK1A Stimulates Human β-Cell Proliferation
- (2016) Ercument Dirice et al. DIABETES
- Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors To Explore a MEK Resistance Hypothesis
- (2015) Jason G. Kettle et al. JOURNAL OF MEDICINAL CHEMISTRY
- A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
- (2015) Peng Wang et al. NATURE MEDICINE
- Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
- (2015) Weijun Shen et al. Nature Communications
- Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance
- (2014) Latif Rachdi et al. CELL CYCLE
- A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr286, not Thr288
- (2013) Anne L. Ashford et al. BIOCHEMICAL JOURNAL
- Pyrido[2,3-d]pyrimidines: Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors
- (2013) Kevin Anderson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Mirk/dyrk1B Kinase in Ovarian Cancer
- (2013) Eileen Friedman INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Development of DANDYs, New 3,5-Diaryl-7-azaindoles Demonstrating Potent DYRK1A Kinase Inhibitory Activity
- (2013) Stéphanie Gourdain et al. JOURNAL OF MEDICINAL CHEMISTRY
- New kinase targets for Alzheimer's disease
- (2013) Monica Hoyos Flight NATURE REVIEWS DRUG DISCOVERY
- Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer’s?
- (2012) Breland Smith et al. ACS Chemical Neuroscience
- Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B
- (2012) Tania Tahtouh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)
- (2011) Andrew S. Rosenthal et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles
- (2010) Sergi Aranda et al. FASEB JOURNAL
- The role of DYRK1A in neurodegenerative diseases
- (2010) Jerzy Wegiel et al. FEBS Journal
- Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
- (2010) Yasushi Ogawa et al. Nature Communications
- The Kinase Mirk/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer
- (2010) Eileen Friedman Cancers
- Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation
- (2009) Nora Göckler et al. FEBS Journal
- Role for DYRK family kinases on regulation of apoptosis
- (2008) Kiyotsugu Yoshida BIOCHEMICAL PHARMACOLOGY
- Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome
- (2008) Fei Liu et al. FASEB JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started